Delivery Order SPE2DB20D1109-SPE2DB25FP74W
Award Date 9/12/25
Potential Completion Date 9/15/25
Potential Value $2.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,192.05 to AmerisourceBergen Drug Corp for CREXONT ER 87.5 mg-350 mg capsules (120-count supply). This is a firm fixed-price delivery order with no set-aside designation, completed on September 3, 2025, and performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order under its...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for CREXONT ER 70 mg–280 mg capsules (120-count packaging) with a ceiling value of $3,237.83. This firm fixed-price delivery order is non-competitive, representing one of numerous pharmaceutical supply transactions executed through AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The contract will be performed at the company's...
- The Defense Logistics Agency awarded a $2,614.19 delivery order to AmerisourceBergen Drug Corp for CREXONT ER 52.5 mg-210 mg capsules (120-count) on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed price, non-set-aside contract represents a direct procurement of pharmaceutical products to support federal medical supply needs. The award was performed from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,881.19 delivery order to AmerisourceBergen Drug Corp for Crexont ER 87.5 mg-350 mg capsules (120 count) on August 21, 2025, with ultimate completion by August 22, 2025. This firm fixed-price delivery order represents a non-competitive set-aside contract utilizing competitively-awarded pricing. The product will be performed at AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $2,501.63 to AmerisourceBergen Drug Corp for Crexont ER 70 MG-280 MG capsules (120-count supply) on August 4, 2025, with completion scheduled for August 5, 2025. This non-competitive delivery order utilizes firm fixed pricing and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as a critical pharmaceutical supplier to federal...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $3,342.98 to AmerisourceBergen Drug Corp for the supply of Crexont ER 70 mg-280 mg capsules (120 count) on July 21, 2025, with ultimate completion scheduled for July 22, 2025. This non-set-aside, firm fixed-price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,989.09 to AmerisourceBergen Drug Corp for Crexont ER (87.5 mg-350 mg capsules, 120 count) on September 10, 2025, with an ultimate completion date of September 11, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a competitive award under DLA's existing pharmaceutical supply contract vehicle. The product will be delivered to AmerisourceBergen's corporate office location...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,315.07, is for the delivery of 4567615784 ! CREXONT ER 87.5 MG-350 MG CAP 120S, a medical product, with a performance period ending on March 19, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,162.02 firm-fixed-price contract is for the delivery of CREXONT ER 52.5 MG-210 MG capsules, with a completion date of March 26, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,350.38 firm fixed-price delivery order contract is for the supply of 4567968327 ! CREXONT ER 52.5 MG-210 MG CAP 120S, a pharmaceutical product. The contract is not set aside and has an ultimate completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...